Global Pharmaceutical Microcrystalline Cellulose 麻豆原创 Research Report 2023

Publication ID:

PB504238905

Publication Date:

May 26, 2023

Pages:

109

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Pharmaceutical Microcrystalline Cellulose market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Pharmaceutical Microcrystalline Cellulose is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pharmaceutical Microcrystalline Cellulose is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Pharmaceutical Microcrystalline Cellulose include International Flavors & Fragrances, JRS Pharma, Shin-Etsu Chemical Co., Ltd., Ashland, Asahi Kasei, Mingtai, Huzhou Zhanwang, Sunhere Pharmaceutical Excipients and Shandong HEAD, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Microcrystalline Cellulose, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Microcrystalline Cellulose.
The Pharmaceutical Microcrystalline Cellulose market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pharmaceutical Microcrystalline Cellulose market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Microcrystalline Cellulose manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
International Flavors & Fragrances
JRS Pharma
Shin-Etsu Chemical Co., Ltd.
Ashland
Asahi Kasei
Mingtai
Huzhou Zhanwang
Sunhere Pharmaceutical Excipients
Shandong HEAD
Lotte Chemicals
Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
Yingkou AODA Pharmaceuticals
Accent Microcell
Qufu TIANLI MEDICAL Supplements
C & J Chemical Industries Co., Ltd.
Segment by Type
Particle Size Less Than 50 Microns
Particle Size 50-100 Microns
Particle Size Greater Than 100 Microns
Segment by Application
Sustained Release Preparation
Tablet
Capsule
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Microcrystalline Cellulose manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Microcrystalline Cellulose in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Overview
1.1 Product Overview and Scope of Pharmaceutical Microcrystalline Cellulose
1.2 Pharmaceutical Microcrystalline Cellulose Segment by Type
1.2.1 Global Pharmaceutical Microcrystalline Cellulose 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Particle Size Less Than 50 Microns
1.2.3 Particle Size 50-100 Microns
1.2.4 Particle Size Greater Than 100 Microns
1.3 Pharmaceutical Microcrystalline Cellulose Segment by Application
1.3.1 Global Pharmaceutical Microcrystalline Cellulose 麻豆原创 Value by Application: (2023-2029)
1.3.2 Sustained Release Preparation
1.3.3 Tablet
1.3.4 Capsule
1.4 Global Pharmaceutical Microcrystalline Cellulose 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Microcrystalline Cellulose Revenue 2018-2029
1.4.2 Global Pharmaceutical Microcrystalline Cellulose Sales 2018-2029
1.4.3 Global Pharmaceutical Microcrystalline Cellulose 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Competition by Manufacturers
2.1 Global Pharmaceutical Microcrystalline Cellulose Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Pharmaceutical Microcrystalline Cellulose Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Pharmaceutical Microcrystalline Cellulose Average Price by Manufacturers (2018-2023)
2.4 Global Pharmaceutical Microcrystalline Cellulose Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pharmaceutical Microcrystalline Cellulose, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Microcrystalline Cellulose, Product Type & Application
2.7 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Competitive Situation and Trends
2.7.1 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Microcrystalline Cellulose Players 麻豆原创 Share by Revenue
2.7.3 Global Pharmaceutical Microcrystalline Cellulose 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Microcrystalline Cellulose Retrospective 麻豆原创 Scenario by Region
3.1 Global Pharmaceutical Microcrystalline Cellulose 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pharmaceutical Microcrystalline Cellulose Global Pharmaceutical Microcrystalline Cellulose Sales by Region: 2018-2029
3.2.1 Global Pharmaceutical Microcrystalline Cellulose Sales by Region: 2018-2023
3.2.2 Global Pharmaceutical Microcrystalline Cellulose Sales by Region: 2024-2029
3.3 Global Pharmaceutical Microcrystalline Cellulose Global Pharmaceutical Microcrystalline Cellulose Revenue by Region: 2018-2029
3.3.1 Global Pharmaceutical Microcrystalline Cellulose Revenue by Region: 2018-2023
3.3.2 Global Pharmaceutical Microcrystalline Cellulose Revenue by Region: 2024-2029
3.4 North America Pharmaceutical Microcrystalline Cellulose 麻豆原创 Facts & Figures by Country
3.4.1 North America Pharmaceutical Microcrystalline Cellulose 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2029)
3.4.3 North America Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Microcrystalline Cellulose 麻豆原创 Facts & Figures by Country
3.5.1 Europe Pharmaceutical Microcrystalline Cellulose 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2029)
3.5.3 Europe Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Microcrystalline Cellulose 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Microcrystalline Cellulose 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2029)
3.6.3 Asia Pacific Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Microcrystalline Cellulose 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Microcrystalline Cellulose 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2029)
3.7.3 Latin America Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Microcrystalline Cellulose 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Microcrystalline Cellulose 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Microcrystalline Cellulose Sales by Type (2018-2029)
4.1.1 Global Pharmaceutical Microcrystalline Cellulose Sales by Type (2018-2023)
4.1.2 Global Pharmaceutical Microcrystalline Cellulose Sales by Type (2024-2029)
4.1.3 Global Pharmaceutical Microcrystalline Cellulose Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Pharmaceutical Microcrystalline Cellulose Revenue by Type (2018-2029)
4.2.1 Global Pharmaceutical Microcrystalline Cellulose Revenue by Type (2018-2023)
4.2.2 Global Pharmaceutical Microcrystalline Cellulose Revenue by Type (2024-2029)
4.2.3 Global Pharmaceutical Microcrystalline Cellulose Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Pharmaceutical Microcrystalline Cellulose Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pharmaceutical Microcrystalline Cellulose Sales by Application (2018-2029)
5.1.1 Global Pharmaceutical Microcrystalline Cellulose Sales by Application (2018-2023)
5.1.2 Global Pharmaceutical Microcrystalline Cellulose Sales by Application (2024-2029)
5.1.3 Global Pharmaceutical Microcrystalline Cellulose Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Pharmaceutical Microcrystalline Cellulose Revenue by Application (2018-2029)
5.2.1 Global Pharmaceutical Microcrystalline Cellulose Revenue by Application (2018-2023)
5.2.2 Global Pharmaceutical Microcrystalline Cellulose Revenue by Application (2024-2029)
5.2.3 Global Pharmaceutical Microcrystalline Cellulose Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Pharmaceutical Microcrystalline Cellulose Price by Application (2018-2029)
6 Key Companies Profiled
6.1 International Flavors & Fragrances
6.1.1 International Flavors & Fragrances Corporation Information
6.1.2 International Flavors & Fragrances Description and Business Overview
6.1.3 International Flavors & Fragrances Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.1.4 International Flavors & Fragrances Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.1.5 International Flavors & Fragrances Recent Developments/Updates
6.2 JRS Pharma
6.2.1 JRS Pharma Corporation Information
6.2.2 JRS Pharma Description and Business Overview
6.2.3 JRS Pharma Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.2.4 JRS Pharma Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.2.5 JRS Pharma Recent Developments/Updates
6.3 Shin-Etsu Chemical Co., Ltd.
6.3.1 Shin-Etsu Chemical Co., Ltd. Corporation Information
6.3.2 Shin-Etsu Chemical Co., Ltd. Description and Business Overview
6.3.3 Shin-Etsu Chemical Co., Ltd. Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Shin-Etsu Chemical Co., Ltd. Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.3.5 Shin-Etsu Chemical Co., Ltd. Recent Developments/Updates
6.4 Ashland
6.4.1 Ashland Corporation Information
6.4.2 Ashland Description and Business Overview
6.4.3 Ashland Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ashland Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.4.5 Ashland Recent Developments/Updates
6.5 Asahi Kasei
6.5.1 Asahi Kasei Corporation Information
6.5.2 Asahi Kasei Description and Business Overview
6.5.3 Asahi Kasei Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Asahi Kasei Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.5.5 Asahi Kasei Recent Developments/Updates
6.6 Mingtai
6.6.1 Mingtai Corporation Information
6.6.2 Mingtai Description and Business Overview
6.6.3 Mingtai Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mingtai Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.6.5 Mingtai Recent Developments/Updates
6.7 Huzhou Zhanwang
6.6.1 Huzhou Zhanwang Corporation Information
6.6.2 Huzhou Zhanwang Description and Business Overview
6.6.3 Huzhou Zhanwang Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Huzhou Zhanwang Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.7.5 Huzhou Zhanwang Recent Developments/Updates
6.8 Sunhere Pharmaceutical Excipients
6.8.1 Sunhere Pharmaceutical Excipients Corporation Information
6.8.2 Sunhere Pharmaceutical Excipients Description and Business Overview
6.8.3 Sunhere Pharmaceutical Excipients Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sunhere Pharmaceutical Excipients Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.8.5 Sunhere Pharmaceutical Excipients Recent Developments/Updates
6.9 Shandong HEAD
6.9.1 Shandong HEAD Corporation Information
6.9.2 Shandong HEAD Description and Business Overview
6.9.3 Shandong HEAD Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Shandong HEAD Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.9.5 Shandong HEAD Recent Developments/Updates
6.10 Lotte Chemicals
6.10.1 Lotte Chemicals Corporation Information
6.10.2 Lotte Chemicals Description and Business Overview
6.10.3 Lotte Chemicals Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Lotte Chemicals Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.10.5 Lotte Chemicals Recent Developments/Updates
6.11 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
6.11.1 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Corporation Information
6.11.2 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Description and Business Overview
6.11.3 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.11.5 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Yingkou AODA Pharmaceuticals
6.12.1 Yingkou AODA Pharmaceuticals Corporation Information
6.12.2 Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Description and Business Overview
6.12.3 Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.12.5 Yingkou AODA Pharmaceuticals Recent Developments/Updates
6.13 Accent Microcell
6.13.1 Accent Microcell Corporation Information
6.13.2 Accent Microcell Pharmaceutical Microcrystalline Cellulose Description and Business Overview
6.13.3 Accent Microcell Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Accent Microcell Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.13.5 Accent Microcell Recent Developments/Updates
6.14 Qufu TIANLI MEDICAL Supplements
6.14.1 Qufu TIANLI MEDICAL Supplements Corporation Information
6.14.2 Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Description and Business Overview
6.14.3 Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.14.5 Qufu TIANLI MEDICAL Supplements Recent Developments/Updates
6.15 C & J Chemical Industries Co., Ltd.
6.15.1 C & J Chemical Industries Co., Ltd. Corporation Information
6.15.2 C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Description and Business Overview
6.15.3 C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Sales, Revenue and Gross Margin (2018-2023)
6.15.4 C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Product Portfolio
6.15.5 C & J Chemical Industries Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Microcrystalline Cellulose Industry Chain Analysis
7.2 Pharmaceutical Microcrystalline Cellulose Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Microcrystalline Cellulose Production Mode & Process
7.4 Pharmaceutical Microcrystalline Cellulose Sales and 麻豆原创ing
7.4.1 Pharmaceutical Microcrystalline Cellulose Sales Channels
7.4.2 Pharmaceutical Microcrystalline Cellulose Distributors
7.5 Pharmaceutical Microcrystalline Cellulose Customers
8 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Dynamics
8.1 Pharmaceutical Microcrystalline Cellulose Industry Trends
8.2 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Drivers
8.3 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Challenges
8.4 Pharmaceutical Microcrystalline Cellulose 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

International Flavors & Fragrances
JRS Pharma
Shin-Etsu Chemical Co., Ltd.
Ashland
Asahi Kasei
Mingtai
Huzhou Zhanwang
Sunhere Pharmaceutical Excipients
Shandong HEAD
Lotte Chemicals
Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
Yingkou AODA Pharmaceuticals
Accent Microcell
Qufu TIANLI MEDICAL Supplements
C & J Chemical Industries Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.